TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.70$ +4.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NRXS
Line item 2020 2021 2022 2023 2024 2025
– -72.7% +94.7% -65.6% +833.8% +34.6%
– -80.1% -2.9% -49.1% +1,658.5% +34.4%
– -83.1% -20.9% -69.0% +4,605.8% +34.3%
– -83.1% -20.9% -69.0% +4,605.8% +34.3%
– -63.0% +51.3% -58.0% +234.3% -20.0%
– -63.3% +22.9% -55.9% +108.9% +480.1%
– -18.6% – – – –
– -7.5% +223.8% +39.3% -10.6% +184.5%
– +38.4% +344.7% -72.9% +40.6% +11.7%
– +41.3% +389.7% -73.0% +29.0% +14.7%
– +59.5% +88.0% -62.3% +10.0% -1.3%
– +194.0% +229.1% -24.4% -50.4% -76.7%
– – – – – –
– -150.2% – – – +64.4%
– – – – – –
– +0.0% +56.3% -25.2% +9.9% +31.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?